Bide Pharmatech Co Ltd
SSE:688073
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Bide Pharmatech Co Ltd
Other Operating Expenses
Bide Pharmatech Co Ltd
Other Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bide Pharmatech Co Ltd
SSE:688073
|
Other Operating Expenses
¥8.4m
|
CAGR 3-Years
32%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Other Operating Expenses
¥1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
155%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Other Operating Expenses
¥399.1m
|
CAGR 3-Years
47%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Other Operating Expenses
¥49.8m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
-8%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Other Operating Expenses
¥245.1m
|
CAGR 3-Years
14%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Other Operating Expenses
¥43.3m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
Bide Pharmatech Co Ltd
Glance View
Bide Pharmatech Co., Ltd. engages in research and development of drugs. The company is headquartered in Shanghai, Shanghai and currently employs 617 full-time employees. The company went IPO on 2022-10-11. The firm's main businesses are the research, development, design, production and sales of drug molecular building blocks. The firm's main products are pharmaceutical molecular building blocks and scientific reagents. The firm's products are mainly used in drug target discovery, seed compound screening, lead compound discovery, synthesis and optimization. The firm conducts business in Asia Pacific, India, Europe, the United States and other regions.
See Also
What is Bide Pharmatech Co Ltd's Other Operating Expenses?
Other Operating Expenses
8.4m
CNY
Based on the financial report for Dec 31, 2024, Bide Pharmatech Co Ltd's Other Operating Expenses amounts to 8.4m CNY.
What is Bide Pharmatech Co Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
29%
Over the last year, the Other Operating Expenses growth was 62%. The average annual Other Operating Expenses growth rates for Bide Pharmatech Co Ltd have been 32% over the past three years , 29% over the past five years .
